Post-Market Surveillance (PMS) Services for Medical Devices (EU MDR Compliance)
Our Post-Market Surveillance (PMS) services support medical device manufacturers in maintaining ongoing compliance with EU MDR requirements. Patient Guard provides expert guidance to ensure your PMS system effectively monitors device safety, performance, and regulatory compliance throughout the product lifecycle.
Post-Market Surveillance (PMS) Services
Post-Market Surveillance (PMS) is a mandatory requirement under EU MDR (EU 2017/745) and forms a critical part of the medical device lifecycle.
Manufacturers must establish, implement, and maintain a PMS system to proactively collect and analyse post-market data related to device safety, performance, and usability.
A compliant PMS system supports ongoing Clinical Evaluation, Risk Management, and vigilance activities while demonstrating continued benefit-risk acceptability.
Patient Guard acts as your regulatory consultancy partner, supporting the development, implementation, and maintenance of compliant PMS documentation aligned with EU MDR and MDCG guidance.
Without an effective PMS system, manufacturers risk Notified Body non-conformities, regulatory delays, and potential market restrictions.
Patient Guard provides expert PMS services tailored to your device classification, intended use, and regulatory obligations, ensuring compliance and audit readiness.
New to the EU Medical Device Regulation (MDR)?
This page explains Patient Guard’s Post-Market Surveillance (PMS) and Vigilance services, helping manufacturers meet their ongoing obligations after placing medical devices on the market. If you're looking for a broader introduction to the EU Medical Device Regulation (MDR), including CE marking, manufacturer responsibilities, Technical Documentation, Risk Management, Clinical Evaluation and the requirements for Post-Market Surveillance under Articles 83–86, read our MDR for Beginners – Complete Guide.
Why Choose Patient Guard for Medical Device PMS?
Proactive Data Systems
We build PMS frameworks that move beyond reactive complaint handling. We design proactive data-gathering strategies that spot safety trends and satisfy strict regulatory expectations.
MDR, IVDR & MHRA Expertise
We deeply understand the shifting timelines and reporting rules across the UK and Europe, keeping your PMS plans completely aligned with Notified Body and MHRA standards.
End-to-End File Continuity
Our regulatory team seamlessly links your post-market data back into your ISO 14971 Risk Files and Clinical Evaluations (CER/PER), closing the loop required for compliance.
What Our PMS Service Includes
PMS Plans & Reports
We generate compliant Post-Market Surveillance Plans alongside final Post-Market Surveillance Reports (PMSR) customized cleanly to your product's classification group.
PSUR Generation
For higher-risk devices, we author and update comprehensive Periodic Safety Update Reports (PSUR) outlining risk-benefit ratios to ensure seamless submission readies.
Vigilance & Incident Reporting
We guide you through time-sensitive adverse event monitoring, trend analysis, and direct regulatory notification pathways to handle incident reporting with confidence.
PMCF & PMPF Integration
We map out robust Post-Market Clinical Follow-up (PMCF) or Performance Follow-up (PMPF) methods to actively collect ongoing clinical performance data.
Audit Preparation & Support
We evaluate your legacy post-market files against modern standards, leading robust mock gap assessments to keep your data ready for Notified Body reviews.
Who Requires PMS?
- Medical device manufacturers under EU MDR
- Companies seeking CE marking
- Class I, IIa, IIb, and III device manufacturers
- Organisations undergoing Notified Body review
- Companies requiring PSUR or PMS documentation updates
EU MDR PMS Requirements
Under EU MDR, manufacturers must:
- Establish and maintain a PMS system
- Develop a PMS Plan
- Collect and analyse post-market data
- Prepare PMS Reports or PSURs
- Implement corrective and preventive actions where necessary
- Integrate findings into risk management and clinical evaluation
A compliant PMS system is essential for demonstrating ongoing device safety and regulatory compliance.
Our Process
Step 1 – PMS Strategy & Planning
We assess your device classification, intended use, and regulatory obligations to develop a compliant PMS strategy
Step 2 – Data Collection & Analysis
We establish post-market data collection methods and evaluate complaints, feedback, vigilance, and trend data
Step 3 – PMS Reporting & Compliance
We prepare PMS Reports or PSURs and align outputs with CER, PMCF, and risk management documentation
Industries We Support
We support PMS services across:
- Medical device manufacturers
- Implantable device companies
- Digital health and SaMD
- Start-ups and global manufacturers
Cost of Service
Post Market Surveillance Services
ph
Ensure regulatory compliance and market readiness with expertly prepared PMS Plans, PMS Reports and PSURs.
Features
- PMS Plan development aligned with EU MDR Article 84 and Annex III requirements
- PMS Report and PSUR preparation for ongoing regulatory compliance and Notified Body review
- Complaint, vigilance, and trend analysis to support proactive post-market monitoring
- Integration of PMS outputs with Clinical Evaluation, PMCF, and Risk Management documentation
Time Lines
Weeks 1–2 – PMS Strategy & Planning
Assess device classification, intended use, and regulatory obligations to develop a compliant PMS Plan
Weeks 3–6 – Data Collection & Analysis
Establish PMS processes and analyse complaints, vigilance, trend data, and post-market feedback
Weeks 7–10 – PMS Reporting & Compliance
Prepare PMS Reports or PSURs and align outputs with CER, PMCF, and risk management documentation
Frequently Asked Questions (FAQs)
What is Post-Market Surveillance (PMS)?
PMS is the process of proactively collecting and analysing post-market data to ensure continued device safety and performance.
Is PMS mandatory under EU MDR?
Yes, PMS is a mandatory requirement for all medical devices under EU MDR.
What is the difference between a PMS Report and a PSUR?
A PMS Report is generally required for Class I devices, while a PSUR is required for Class IIa, IIb, and III devices.
How often should PMS documentation be updated?
Updates depend on device classification and regulatory requirements, but PMS activities must remain ongoing throughout the product lifecycle.
How does PMS relate to PMCF and CER?
PMS data supports ongoing Clinical Evaluation, PMCF activities, and Risk Management updates.
Related Services
Click on the links below to discover more:
Do you need Training?
Check out Patient Guards Training Courses
Recent Blog Posts
DCB0129 and Clinical Safety: What Digital Health Manufacturers Need for NHS DTAC
For digital health manufacturers preparing to enter the NHS, clinical safety can be one of the most important—and sometimes misunderstood—parts of DTAC.
It is not enough to demonstrate that your software works.
Manufacturers need to consider what could happen if the technology fails, produces incorrect information, presents information incorrectly, contributes to a workflow error or is used in circumstances that could expose patients to harm.
This is where clinical risk management and DCB0129 become particularly important.
NHS England identifies DCB0129 as the clinical risk management standard for manufacturers of health IT systems. Its counterpart, DCB0160, applies to health organisations deploying and using health IT systems. NHS England states that compliance with these standards is required under the Health and Social Care Act 2012.
For manufacturers working towards NHS DTAC readiness, understanding the distinction—and having the right clinical safety evidence—is essential.
DTAC Requirements Explained: The 5 Areas Digital Health Manufacturers Need to Get Right
If your digital health technology is heading towards the NHS, understanding the Digital Technology Assessment Criteria (DTAC) should be part of your market-access planning.
But one of the biggest mistakes manufacturers can make is treating DTAC as simply another questionnaire to complete.
The questions are only part of the process.
Behind your answers needs to be evidence showing that your technology and organisation have appropriate arrangements for clinical safety, data protection, technical security, interoperability, and usability and accessibility.
These five areas form the core of NHS DTAC. NHS England describes DTAC as national baseline criteria for digital health technologies entering NHS and social care.
For digital health manufacturers, the practical question is therefore not simply:
“Can we complete the DTAC assessment?”
It is:
“Can we demonstrate that our product meets the requirements?”
This guide looks at each of the five DTAC areas, the types of evidence manufacturers should consider and some of the common gaps that can delay NHS readiness.
The Complete Guide to NHS DTAC Compliance for Digital Health Manufacturers
A complete guide to NHS DTAC compliance for digital health manufacturers, covering the five DTAC assessment areas, required evidence, clinical safety, data protection, technical security, interoperability and usability, and how to prepare your digital health technology for NHS procurement.
Cosmetic Product Safety Report (CPSR): A Complete Guide to UK Cosmetic Compliance
Before a cosmetic product can legally be placed on the UK market, manufacturers and Responsible Persons must demonstrate that it is safe for human use under normal or reasonably foreseeable conditions. The Cosmetic Product Safety Report (CPSR) is one of the most important regulatory documents required under the UK Cosmetics Regulation. This guide explains what a CPSR is, who can prepare one, what information it must contain, how it relates to the Product Information File (PIF) and how it supports legal cosmetic compliance.
IVDR PMPF Explained: A Complete Guide to Post-Market Performance Follow-up
Post-Market Performance Follow-up (PMPF) is a fundamental requirement under the EU In Vitro Diagnostic Regulation (IVDR), ensuring that manufacturers continually monitor the scientific validity, analytical performance and clinical performance of their in vitro diagnostic medical devices after CE marking. This guide explains IVDR PMPF requirements, PMPF Plans, PMPF Reports, Annex XIII expectations and how ongoing performance monitoring supports continued regulatory compliance throughout the device lifecycle.
IVDR Scientific Validity Explained: A Complete Guide for Manufacturers
Scientific Validity is the first pillar of IVDR Performance Evaluation and provides the scientific foundation demonstrating that an analyte or biomarker is associated with a specific clinical condition or physiological state. This guide explains Scientific Validity under Regulation (EU) 2017/746, including literature reviews, Scientific Validity Reports, Annex XIII requirements, evidence appraisal and how Scientific Validity supports successful CE marking.
